PAHC
Phibro Animal Health CorporationHealthcare · $1.4B market cap
Verdict
Share price
$37.24
close of Oct 3, 2026
Fair value
$56.46
Sticker Price
Payback Price
$22.59
buy price
PAHC is Undervalued: at $37.24 it trades 34% below its fair value of $56.46. Its buy price (Payback Price) is $22.59, 39% below today's price. Business quality is limited: only 1 of 5 key numbers clears the 10% bar.
How we valued it
Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.
Business quality
1 of 5 clear the 10% bar. What are the Big Five?
Follow PAHC
Get notified when it reaches its buy price of $22.59. Free.
Create a free accountSuperinvestors
None of the investors we track holds PAHC right now. In Q2 2026, 1 sold out. Who we track
Moves in Q2 2026
Sold out: Polen Capital Management
Insider activity
Since Jul 1, 2026: no open-market purchases and 15 other filings (stock awards, tax withholding and similar). Why purchases matter
Other filings
Bendheim Daniel M
President and CEO · 2026-08-06
Award
11,699 shares
Escudero Lisa Ann
See Remarks · 2026-08-06
Award
1,547 shares
BENDHEIM JACK
Executive Chairman · 2026-08-06
Award
12,103 shares
Weinstein Judith
See Remarks · 2026-08-06
Award
2,478 shares
BENDHEIM Jonathan
director · 2026-08-06
Award
2,716 shares
Show all 15 other filingsShow fewer
Miller Larry Lee
Chief Operating Officer · 2026-08-06
Award
3,522 shares
David Glenn
Chief Financial Officer · 2026-08-06
Award
3,334 shares
Rodriguez Patrick
VP Finance and Treasurer · 2026-08-06
Award
1,503 shares
Bendheim Daniel M
President and CEO · 2026-08-04
J-Other
$18K
David Glenn
Chief Financial Officer · 2026-08-04
J-Other
$31K
Weinstein Judith
See Remarks · 2026-08-04
J-Other
$17K
Miller Larry Lee
Chief Operating Officer · 2026-08-04
J-Other
$23K
Escudero Lisa Ann
See Remarks · 2026-08-04
J-Other
$10K
BENDHEIM JACK
Executive Chairman · 2026-08-04
J-Other
$84K
Bendheim Daniel M
President and CEO · 2026-07-01
Award
300,000 shares
About Phibro Animal Health Corporation
Phibro Animal Health Corporation operates as a global entity focused on the research, production, and supply of a wide array of animal health and mineral nutrition solutions. While serving a global clientele, its primary market for livestock products is the United States. The company's operations are divided into three main business segments: Animal Health, Mineral Nutrition, and Performance Products. Phibro…
Drug Manufacturers - Specialty & Generic
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works